ClinicalTrials.gg
RecruitingNCT07883187Updated Oct 22, 2026

Clinical Evaluation of Bioflx Crowns in Restoring Primary Anterior Teeth

An interventional study of Bioflx Crown Restoration (Group I) and Celluloid Strip Crown Restoration (Group II) in Clinical, Primary Teeth and Restoration, sponsored by Tanta University. Recruiting at 1 site in Egypt. Open to participants aged 3 Years to 5 Years. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by Tanta University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Nov 2025, registered Oct 2026).
  • Started Nov 2025; still recruiting 11 months later.
Updated Oct 22, 2026Primary outcomes revisedNewly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
3 Years to 5 Years
Sex
All
01

Study summary

This randomized controlled clinical trial evaluates and compares the clinical success and performance of prefabricated Bioflx crowns versus conventional Celluloid strip crowns in the restoration of badly decayed or traumatized primary anterior teeth.

Read the detailed description

forty pediatric patients aged 3 to 5 years presenting with bilateral multi-surface carious primary anterior teeth requiring full coronal restoration are enrolled. Each child receives a Bioflx crown on one target tooth (Group I) and a Celluloid strip crown on the contralateral target tooth (Group II). Clinical outcomes are systematically evaluated at 3, 6, and 9 months post-operative using Modified United States Public Health Service (USPHS) criteria (assessing marginal integrity, color match, restoration integrity/failure rate, and proximal contacts) along with Silness-Löe Plaque and Gingival Indices.

02

Conditions studied

  • Clinical
  • Primary Teeth
  • Restoration
  • Crown

Keywords

  • Bioflx
  • Celluloid Strip Crowns
  • Primary Anterior Teeth
  • clinical evaluation
03

In context

Lead sponsor

Tanta University is the lead sponsor of 987 studies on the registry; 313 are open to participants now.

Of its 16 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 5 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy children aged 3-5 years with cooperative behavior (Frankl's behavior rating scale 3-4).
  • Bilateral anterior primary teeth affected by multi-surface caries requiring full coronal restoration.
  • At least two-thirds of the root structure is present, and adequate coronal tooth structure to retain the crown.

Exclusion criteria

Exclusion Criteria:

  • Non-restorable teeth
  • Teeth with single-surface restorations.
  • Previous full-coverage restoration or large unsuccessful restoration on the target tooth.
  • Children with oral parafunctional habits (e.g., thumb sucking, bruxism).
  • Advanced physiologic root resorption (>1/3).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Group I - Experimental Group (Bioflx Crowns)

    Carious primary anterior teeth prepared and restored using prefabricated translucent hybrid resin Bioflx pediatric crowns cemented with glass ionomer cement.

    Procedure: Bioflx Crown Restoration (Group I)

  • Active comparator
    Group II - Control Group (Celluloid Strip Crowns)

    Carious primary anterior teeth prepared, etched, bonded, and restored using resin composite filled inside Celluloid strip crown forms.

    Procedure: Celluloid Strip Crown Restoration (Group II)

Interventions

  • ProcedureBioflx Crown Restoration (Group I)

    Preparation: Administration of 2% lidocaine local anesthesia with epinephrine; caries removal; 1-1.5 mm incisal reduction; 1 mm mesial/distal contact breaking using diamond burs; minimal labial/palatal reduction; rounding of sharp line angles. Seating \& Cementation: Selection of appropriate Bioflx crown size via mesiodistal caliper measurement; crown try-in; cavity sealing and final cementation using self-curing glass ionomer cement (IMICRYL Nova); excess cement removal with explorer and dental floss.

  • ProcedureCelluloid Strip Crown Restoration (Group II)

    Preparation: Local anesthesia administration; caries removal; shade selection; incisal and proximal reduction. Matrix \& Bonding: Celluloid strip crown form selected, trimmed to length, verified for cervical adaptation, and vented at the incisal edge. Enamel etched with 37% phosphoric acid (CharmEtch) for 15 seconds, rinsed, and dried. Universal bonding agent (All-Bond Universal) applied and light-cured for 15 seconds. Placement \& Finishing: Crown form filled with shade-matched composite resin (Beautifil), seated firmly on the tooth, excess material removed, and light-cured. Celluloid form stripped off using an excavator; final polishing performed.

06

What researchers measure

Primary outcomes

  1. Cumulative Restoration Success Rate via Modified USPHS Criteria

    Proportion of restored crowns categorized as clinically successful (expressed as a percentage). Restoration success is defined as achieving Alpha (A) or Bravo (B) ratings across all four Modified USPHS parameters evaluated via visual, explorer, and dental floss inspection: 1. Marginal Integrity (Alpha = smooth adaptation; Bravo = explorer catches); 2. Color Match (Alpha = exact match; Bravo = acceptable mismatch); 3. Restoration Integrity (Alpha = intact; Bravo = small material loss); 4. Proximal Contact (Alpha = normal resistance to floss; Bravo = contact present without resistance). A rating of Charlie (C) or Delta (D) in any single parameter constitutes restoration failure.

    Time frame: Evaluated at 3, 6, and 9 months post-operative.

Secondary outcomes

  1. Gingival Health Response (Gingival Index)

    Measure Description: Evaluation of marginal gingival tissue health surrounding each restored crown using the Löe and Silness Gingival Index (GI) scored from 0 to 3 (0 = Normal gingiva; 1 = Mild inflammation/slight edema; 2 = Moderate inflammation/erythema/bleeding on probing; 3 = Severe inflammation/spontaneous bleeding).

    Time frame: Evaluated at baseline, 3, 6, and 9 months post-operative.

  2. Plaque Index Score around Restored Teeth

    Measure Description: Assessment of soft microbial plaque thickness at the gingival margin surrounding each crown using the Silness-Löe Plaque Index (PI) scored from 0 to 3 (0 = No plaque; 1 = Thin film at gingival margin; 2 = Moderate accumulation; 3 = Abundance of plaque).

    Time frame: Evaluated at baseline, 3, 6, and 9 months post-operative.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Patil AS, Jain M, Choubey S, Patil M, Chunawala Y. Comparative evaluation of clinical success of Stainless Steel and Bioflx crowns in primary molar - A 12 month split mouth prospective randomized clinical trial. J Indian Soc Pedod Prev Dent. 2024 Jan 1;42(1):37-45. doi: 10.4103/JISPPD.JISPPD_484_23. Epub 2024 Apr 15. PubMed 38616425 ↗
  • Agrawal R, Khanduja R, Singhal M, Gupta S, Kaushik M. Clinical Evaluation of Stainless Steel Crown versus Zirconia Crown in Primary Molars: An In Vivo Study. Int J Clin Pediatr Dent. 2022 Jan-Feb;15(1):15-19. doi: 10.5005/jp-journals-10005-2134. PubMed 35528499 ↗
09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Nov 2025 (actual). Primary completion is estimated for Nov 2026, 12 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 13, 2026
First posted
Oct 20, 2026
StartActual
Nov 9, 2025
Primary completionEst.
Nov 2026
CompletionEst.
Dec 2026
Last update
Oct 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Also revised
primary outcomes
Registered
First appeared on the registry
Oct 20, 2026
Show all 2 updates
  1. Oct 22, 2026
    Primary outcomes Revised (2 changes)
  2. Oct 20, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07883187
Lead sponsor
Tanta University
Responsible party
Shaimaa Shaban Mohamed El-desouky (assistant professor of pediatric dentistry, Tanta University) — Principal investigator
First posted
Oct 20, 2026
Start date
Nov 9, 2025
Primary completion
Nov 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Oct 22, 2026

Study contacts

shaimaa eldesouky, assistant professor
Contact
shaimaaeldesouky@dent.tanta.edu.eg
01008994242
Nesma Salah Abd-Elsadek Abd-Ellatif, master
Contact
01003889235

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion